A small retrospective study of stupor identified treatment associations without establishing an optimal medication regimen.
Forty patients were analyzed, and twenty-four met the study’s short-term response definition. Responders more often received electroconvulsive therapy and certain antipsychotic treatment patterns. The authors explored a chlorpromazine-equivalent threshold and explicitly described it as data-driven and exploratory.
The threshold concerns antipsychotic equivalence, not a benzodiazepine conversion or dose target. Treatment selection and multiple simultaneous therapies confound attribution. A cutoff fitted in forty patients requires independent validation, and a predictive association is not a treatment instruction.
For a record review involving benzodiazepines and stupor, separate syndrome recognition, diagnostic uncertainty, and each intervention’s timing. This study cannot establish that a particular benzodiazepine dose was inadequate or that escalating another drug would have changed the outcome. It highlights the limits of retrospective response prediction.
Source reviewed: Clinical predictors of short term treatment response in stupor a retrospective study (PMC12878232). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Benzodiazepine Dose and ICU Restraints: Interpreting a Two-Way Clinical Relationship; Valproate After Benzodiazepines: Why a Pooled Status-Epilepticus Response Rate Needs Context.